B. R. Bharath
N.M.A.M. Institute of Technology
19 Papers
85 Citations
B. R. Bharath is an academic researcher from N.M.A.M. Institute of Technology. The author has contributed to research in topics: Docking (molecular) & Curcumin. The author has an hindex of 8, co-authored 19 publications. Previous affiliations of B. R. Bharath include Kuvempu University.
Chat about Author
Papers
Molecular docking analysis of curcumin analogues against kinase domain of ALK5
Shivananda Kandagalla,B. S. Sharath,B. R. Bharath,Umme Hani,Hanumanthappa Manjunatha +4 more
- 18 Nov 2017
TL;DR: Six curcumin analogues are revealed as promising ALK5 inhibitors with significant binding energy and H-bonding interaction, which is an important hallmark of malignant cancer disease.
Antibacterial and molecular docking studies of entagenic acid, a bioactive principle from seed kernel of Entada pursaetha DC
Shimoga Muddappa Vidya,Venkatarangaiah Krishna,B. K. Manjunatha,K. P. Rajesh,B. R. Bharath,Hanumanthappa Manjunatha +5 more
TL;DR: The entagenic acid showed the high antibacterial activity against B. cereus and B. subtilis with minimal inhibitory concentration of 200 μg ml−1 and possesses better glucosamine-6-phosphate synthase inhibition in molecular docking studies.
25
Neutralization of Naja naja venom induced lethality, edema and myonecrosis by ethanolic root extract of Coix lacryma-jobi.
TL;DR: In this article, the authors used the ethanolic root extract (ERE) of Coix lacryma-jobi for the first time for anti-venom activity against Indian cobra Naja naja venom.
18
Wound healing phytoconstituents from seed kernel of Entada pursaetha DC. and their molecular docking studies with glycogen synthase kinase 3- β
S. M. Vidya,Venkatarangaiah Krishna,B. K. Manjunatha,B. R. Bharath,K. P. Rajesh,Hanumanthappa Manjunatha,K. L. Mankani +6 more
TL;DR: Entagenic acid may be considered as good inhibitor of GSK3-β, a main target for wound healing activity by Wnt signaling pathway among the phytoconstituents subjected to molecular docking studies for the inhibition of glycogen synthase kinase 3-β protein.
17